Table 2. Summary of the Results of Fig 2... | American Society of Hematology

Table 2.

Summary of the Results of Fig 2A and B

Patient No.	Diagnosis	Source of Cells	Northern Blot		Immunoblot
Patient No.	Diagnosis	Source of Cells	Lane	Result	Lane	Result^*
1	AML M2^†	BM	1	++	3	100
2	AML M1	PB	2	−	1	4
3	AML M2	PB	3	+	NA
4	AML M2	PB	4	+	5	58
5	AML M2	BM	5	−	NA
		PB	14	−	NA
6	AML M2	BM	6	+	NA
		PB	7	+	NA
7	AML M4	BM	8	+	NA
8	AML M2	BM	9	−	7	8
9	AML M4	BM	10	−	NA
10	AML M3	BM	11	+	NA
11	AML M4	BM	12	−	NA
12	AML M4	BM	13	−	NA
13	AML M2	PB	15, 20	++	NA
14	AML M3	PB	16	−	NA
15	AML M4	PB	17	−	NA
16	AML M2	BM	19	−	8	13
17	AML M2	PB	22	+	NA
18	AML M2	PB	23	−	NA
19	AML M2	BM	24	−	4	2
20	AML M5	PB	25	+	6	85
21	AML M2	PB	28	−	NA
22	AML M1^†	PB	29	+	2	38
23	AML M2	BM	30	+	NA
24	ALL L2^‡	PB	18	++	NA
25	B-CLL	PB	21	−	NA

Patient No.	Diagnosis	Source of Cells	Northern Blot		Immunoblot
Patient No.	Diagnosis	Source of Cells	Lane	Result	Lane	Result^*
1	AML M2^†	BM	1	++	3	100
2	AML M1	PB	2	−	1	4
3	AML M2	PB	3	+	NA
4	AML M2	PB	4	+	5	58
5	AML M2	BM	5	−	NA
		PB	14	−	NA
6	AML M2	BM	6	+	NA
		PB	7	+	NA
7	AML M4	BM	8	+	NA
8	AML M2	BM	9	−	7	8
9	AML M4	BM	10	−	NA
10	AML M3	BM	11	+	NA
11	AML M4	BM	12	−	NA
12	AML M4	BM	13	−	NA
13	AML M2	PB	15, 20	++	NA
14	AML M3	PB	16	−	NA
15	AML M4	PB	17	−	NA
16	AML M2	BM	19	−	8	13
17	AML M2	PB	22	+	NA
18	AML M2	PB	23	−	NA
19	AML M2	BM	24	−	4	2
20	AML M5	PB	25	+	6	85
21	AML M2	PB	28	−	NA
22	AML M1^†	PB	29	+	2	38
23	AML M2	BM	30	+	NA
24	ALL L2^‡	PB	18	++	NA
25	B-CLL	PB	21	−	NA

Abbreviations: BM, bone marrow; PB, peripheral blood; NA, not analyzed.

The densitometric readings (arbitrary units) of the cyclin A1 band are shown.

First relapse.

This ALL sample also expressed myeloid markers CD13 and CD65.